News

Woebot Health to Present Abstracts on Diversity in Digital Mental...

SAN FRANCISCO – November 10, 2022 – Woebot Health today announced that Chief Clinical Officer Athena Robinson and select Woebot…

San Francisco, CA, SEPTEMBER 27, 2022 – Woebot Health today announced that it has appointed Brad Gescheider as its Chief…

San Francisco, CA, AUGUST 18, 2022 – Woebot Health today announced that it has appointed Robbert Zusterzeel, M.D., Ph.D., M.P.H.,…

The stake in Woebot Health marks Leaps by Bayer’s first investment in mental health

Company recognized for providing evidence-based, meaningfully engaging mental health solutions

Seventy-three percent are interested in scientifically proven mental health chatbots

Substance misuse was a critical topic of concern long before rates of alcohol and drug consumption skyrocketed during the pandemic

Esteemed group to guide Woebot Health’s scientific and clinical vision and accelerate the future of tech-enabled mental healthcare

Veteran digital health executive to accelerate collaborations with payors and providers

Prominent design expert and best-selling author to direct design and content strategy

BlackRock-Managed Funds and Owl Ventures also join new and existing investors to transform mental health care

WB001 is the first digital therapeutic designed to reduce the burden of postpartum depression